echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Six medical points to pay attention to at the 2015 two sessions

    Six medical points to pay attention to at the 2015 two sessions

    • Last Update: 2021-02-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    March 3rd, the two national conferences will be held in Beijing, and a number of major reform measures will be gradually promoted and implemented from this year onwards. All sectors of society will once again focus on the reform and development plans of the Party and the country. What are you going to see? What do you think? Facebook Jun comprehensive multi-party data, collated the pharmaceutical industry in 2015 the six major points of view of the national two sessions, respectively, anti-corruption, medical reform, old-age security, environmental protection, separate second child, state-owned enterprises reform topics, in order to see the officials.
    point of view: anti-corruption
    anti-corruption system anti-corruption is the key word in 2015
    There is no doubt that anti-corruption will become the two sessions again highly concerned about the topic.
    the 18th National Congress, the anti-corruption "storm" continued to intensify, in just over two years of time, on the investigation of more than 80 high-ranking corrupt officials at or above the provincial and ministerial levels, this anti-corruption efforts unprecedented, shocking. But at the top, anti-corruption efforts are far from up to standard. At the Fifth Plenary Session of the 18th Central Commission for Discipline Inspection, Xi made it clear that corruption had decreased, but not disappeared.
    Song Lin, chairman of China Resources Group, was investigated, GSK was fined 3 billion yuan, a number of health and planning committee officials, pharmaceutical industry executives have been "hands-on", the pharmaceutical industry anti-corruption throughout 2014. Chen Ruiping, head of the discipline inspection team of the Central Commission for Discipline Inspection, said in January 2015 that the Commission would continue to maintain a high-pressure situation in 2015 to investigate and prosecute cases of industry misconduct. It should be said that since the opening of 2015, the Central Commission for Discipline Inspection announced a violation of the central eight rules of the spirit of typical cases far more than in previous years, of which the pharmaceutical industry-related first.
    predictably, the issue of anti-corruption will still be widely mentioned at the two upcoming meetings. And how to better through the "system anti-corruption" to eliminate corruption will become the focus of attention in the industry.
    Snation point two: health care reform
    health care reform will be tilted towards the primary health sector
    As of February 26, 2015 at 16:00, according to Xinhua's 2015 two-session hot-spot survey ranking, "health care reform" topic ranked third. In addition, health care reform has received widespread attention at the "two sessions" that have already ended.
    beijing proposed to deepen the reform of public hospitals, comprehensively promote the separation of medicine, implement the policy of multi-point practice of physicians, and encourage and guide social forces to organize medical institutions; Shanghai should speed up the transformation of the operating mechanism of public hospitals, strengthen the overall budget management, adjust the price of basic medical services; Guangdong said it would promote the reform of public hospitals in depth, carry out pilot multi-point practice of physicians, encourage the community to run doctors, and speed up the construction of a diversified medical pattern.
    reform has been one of Li Keqiang's key reforms, the market expects that the reform will become one of the "two sessions" of concern. The issue of drug prices has been the subject of much attention, and although the "Progress for Drug Price Reform Programme" (Draft for Comments) was issued at the end of 2014, the final results have not yet been released. In 2015, China's health reform will focus on primary health care.
    look at point three:
    pension security pension
    ?With the aging trend becoming more and more serious, the old-age problem has been paid more and more attention by the society.
    As early as December 25, 2014, Minister of Human Resources and Social Welfare Yu Weimin said at the National Conference on Human Resources and Social Security that in 2015 the Ministry of Human Resources and Social Welfare will launch an overall plan for the reform of the old-age insurance system and implement the reform of the old-age insurance system in institutions and institutions in due course.
    January 16, 2015, the Ministry of Human and Social Affairs and the Ministry of Finance announced that the minimum basic pension standard for urban and rural residents nationwide has been raised to 70 yuan per person per month, which is the first increase in China's minimum pension standard.
    The upcoming national "two sessions", pensions will still be a high-profile issue, and the test of fair pensions and whether they can be carried forward smoothly, and thus further deepen the reform of the entire income distribution system, will receive special attention.
    This point four: environmental protection
    the torture of raw materials companies
    According to a survey by People's Daily Online, as of February 18, "environmental protection" with 27,605 votes on the list of the top ten topics of concern.
    s ten-sided haze to describe the weather in Beijing is no longer news, but on December 25, 2014, CCTV news reports said that Lu anti-medicine was exposed to a large number of illegal discharge of antibiotic sewage, which made the illegal discharge of seven times a year Lu resistance in the headlines.
    , Shandong Province, a large number of anti-drug waste of antibiotics sewage was exposed by the media, pharmaceutical companies to pollute the environment again has received attention. In recent years, in environmental protection issues, "falling in the head" of pharmaceutical companies are not in the minority, federal pharmaceutical, Haizheng Pharmaceuticals and other large pharmaceutical companies continue to appear in the environmental protection department inspection and rectification list, and some even repeatedly banned, frequently on the list.
    pharmaceutical manufacturing industry pollutant emissions, difficult to control, especially fermentation, chemical synthesis pharmaceutical enterprises, in recent years has become the focus of environmental supervision. In May 2013, seven ministries, including the Ministry of Environmental Protection, the National Development and Reform Commission and the Ministry of Industry and Information Technology, jointly issued the Notice on the Special Action for the Protection of the Health and Environmental Protection of the Masses of Illegal Sewage Enterprises in 2013, with pharmaceutical manufacturing enterprises as one of the priorities for inspection and rectification.
    in the work reports of the local two sessions, the words of environmental control and air pollution control have appeared many times, and many provincial people's congresses have adopted the Regulations on the Prevention and Control of Air Pollution. It is to be expected that there will be more issues on environmental protection and atmospheric governance at the 2015 national conferences.
    point five: single two-child
    when the single two-child policy is fully liberalized?
    ?In 2015, local "two sessions", "as soon as possible" to fully liberalize the two-child policy, "encourage one child, allow two children, strictly prevent three children" has become a new way of thinking of the birth policy. In early February 2015, Zhang Qiwei, director of the Institute of Population and Labor Economics of the Chinese Academy of Social Sciences, told CCTV that the time was ripe to fully liberalize the two children.
    there is no doubt that the "demographic dividend" advantage, which is the driving force of China's economic growth, is disappearing with a series of problems, such as the aging of the Chinese population, the imbalance between men and women, and the shortage of employment.
    this time, whether the family planning policy should be fully liberalized will become the national "two sessions" of the participants hotly debated the issue.
    Sein point six: so-called enterprise reform
    the direction of comprehensive reform of state-owned pharmaceutical enterprises
    In February 2015, it was reported that the top-level reform of state-owned enterprises after several rounds of discussion and revision, is expected to be introduced after the "two sessions." Reported that the reform of state-owned enterprises is expected to be further relaxed, competitive areas of ownership of capital participation in the proportion of equity restrictions will be further relaxed.
    2014, China National Pharmaceutical Group was selected as a pilot for the reform of mixed ownership by state-owned enterprises, including mixed ownership economy, the board of directors to exercise senior management selection performance appraisal compensation management authority and so on. In fact, the second and third-tier subsidiaries of the National Pharmaceutical Group have been mixed ownership.
    With the progress of the reform of state-owned enterprises, the reform of state-owned enterprises is expected to bring about accelerated performance, in the asset integration, capital operation, efficiency and mechanism improvement of the three dimensions of pharmaceutical state-owned enterprises will usher in comprehensive changes, its performance, valuation will have a positive impact, which will greatly affect the future direction of investment opportunities in the industry. (E-Drug Facebook)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.